Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Recruiting 15Active not recruiting 5Suspended 3Completed 3Terminated 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasm Metastasis 1GastroEsophageal Cancer 1Carcinoma 1Adenocarcinoma 1

Interventions

pembrolizumab 18Paclitaxel 15Cisplatin 14Carboplatin 13Radiation 11Nivolumab 10Doxorubicin 10Cyclophosphamide 10Radiotherapy 9Vincristine 8Metformin 7Fluorouracil 7Etoposide 7Cytarabine 7tislelizumab 6Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Leucovorin 6Injections 6Docetaxel 6Bevacizumab 6atezolizumab 5Prednisone 5Pemetrexed 5Oxaliplatin 5Methotrexate 5Lenalidomide 5Irinotecan 5Ipilimumab 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Albumin-Bound Paclitaxel × 30 days × Clear all
NCT04879368 2026-06-10

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Completed
462 enrolled 15 charts
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT05017012 2026-06-05

MK-3475A-C18

Merck Sharp & Dohme LLC

Phase 1 Completed
142 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT03279237 2026-05-18

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Massachusetts General Hospital

Phase 1 Completed
25 enrolled 9 charts
Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡